From: Model composition through model reduction: a combined model of CD95 and NF-κB signaling pathways
Original model | Reduced model | |||
---|---|---|---|---|
№ | Reactions (Kinetics) | Rates (nM/min) | № | Reactions (Kinetics) |
Activation of caspase-8 induced by CD95 | ||||
br1 | CD95L + CD95R → СD95R:СD95L (MA) | 101/100 | br1* | CD95L → DISC (k LR · CCD95R · CCD95L, CCD95R is determined by the formula (14)) |
br2 | FADD + СD95R:СD95L → DISC (MA) | 101/100 | ||
br3 | pro8 + DISC → DISC:pro8 (MA) | 100/10-1 | ||
br4 | pro8 + DISC:pro8 → DISC:pro82 (MA) | 100/10-1 | ||
br5 | DISC:pro82 → DISC:p43/p41 (MA) | 100/10-1 | br2* | pro8 –DISC → casp8 (kDISC_pro8 · Cpro8 · C DISC ) |
br6 | DISC:p43/p41 → casp8 + DISC (MA) | 100/10-1 | ||
Activation of caspase-8 by caspase-3 | ||||
br7 | pro6 -casp3 → casp6 (M-M) | 100/10-1 | br3* | pro8 –casp3 → casp8 (k38 · Ccasp3) |
br8 | pro8 -casp6 → casp8 (M-M) | 10-1/100 | ||
Inhibition of the DISC complex | ||||
br9 | DISC + cFLIPL → DISC:cFLIPL (MA) | 101/100 | br4* | cFLIP + 2·DISC + pro8 → DISC:FLIP:pro8 (kDISC_FLIP · C FLIP · C DISC ) |
br10 | pro8 + DISC:cFLIPL → DISC:cFLIPL:pro8 (MA) | 100 | ||
br11 | DISC + cFLIPS → blocked DISC (MA) | 101/100 | ||
br12 | DISC:pro8 + cFLIPL → DISC:cFLIPL:pro8 (MA) | 10-2/10-3 | br5* | DISC:FLIP:pro8 → p43/p41 (kDFp8 · CDISC:FLIP:pro8) |
br13 | DISC:pro8 + cFLIPS → blocked DISC (MA) | 10-2/10-3 | ||
br14 | DISC:cFLIPL:pro8 → p43/p41 + blocked DISC (MA) | 10-1 | ||
Activation of caspase-9 triggered by cytochrome C | ||||
br15 | Cyt C stored → Cyt C (f release (t)·C CytCstored ) | 102 | br6* | pro9 → cleavage (the formula (16)) |
br16 | Apaf-1 + Cyt C → Cyt C:Apaf-1 (MA) | 102 | ||
br17 | Cyt C:Apaf-1 → Apaf-1 + Cyt C (MA) | 101 | ||
br18 | pro9 + Cyt C:Apaf → Apop (MA) | 100 | ||
br19 | Apop -casp3 → casp9 + Cyt C:Apaf-1 | 100 | ||
(M-M) | ||||
br20 | Apop → casp9 + Cyt C:Apaf-1 (MA) | 10-2 | ||
Activation of Bid | ||||
br21 | pro2 –casp3 → casp2 (M-M) | 100 | br7* | Bid –casp8 → tBid () |
br22 | Bid –casp8 → tBid (M-M) | 100 | ||
br23 | Bid –casp2 → tBid (M-M) | 10-1/100 | br8* | pro2 –casp3 → cleavage () |
Blocking of IAP by Smac | ||||
br24 | Smac stored → Smac (f release (t)·C Smac stored ) | 102 | – | |
br25 | Smac + IAP → IAP:Smac (MA) | 10-5 | ||
br26 | IAP:Smac → Smac + IAP (MA) | 10-5 | ||
Activation of caspases-3 and −7 | ||||
br27 | pro3 –casp8 → casp3 (M-M) | 101/100 | br9* | pro3 –casp8 → casp3 (M-M) |
br28 | pro3 –casp9 → casp3 (M-M) | 10-3/100 | ||
br29 | pro7 –casp8 → casp7 (M-M) | 100/10-1 | br10* | pro7 –casp8 → cleavage () |
br30 | pro7 –casp9 → casp7 (M-M) | 10-5/10-3 | ||
PARP inactivation | ||||
br31 | PARP -casp3 → cPARP (М-М) | 10-1 | br11* | PARP -casp3 → cPARP () |
br32 | PARP –casp7 → cPARP (М-М) | 100/10-1 | ||
Inhibition of caspases-3, -7 and −9 | ||||
br33 | casp3 + IAP → casp3:IAP (МA) | 100 | br12* | casp3 + IAP → inhibition (MA) |
br34 | casp7 + IAP → casp7:IAP (МA) | 10-1 | ||
br35 | casp9 + IAP → casp9:IAP (МA) | 10-3 | ||
br36 | casp3:IAP → casp3 + IAP (МA) | 10-2 | ||
br37 | casp7:IAP → casp7 + IAP (МA) | 10-4/10-3 | ||
br38 | casp9:IAP → casp9 + IAP (МA) | 10-5/10-4 | ||
Production of the virtual variable x aa | ||||
br39 | → x aa (1 − x aa /Km367act + (1 − x aa ) · (k36act · Ccasp3 + k36act · Ccasp6 + k7act · Ccasp7)) | 100 | br13* | → x aa () |